By Zacks Equity Research   On Apr 11, we updated our research report onNuVasive, Inc. NUVA, a leading player in the global spine market, focused on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The stock currently carries a Zacks Rank #3 (Hold). NuVasive expects its international business to grow by 38% at […]